2024-03-29T11:03:53Z
https://tsukuba.repo.nii.ac.jp/oai
oai:tsukuba.repo.nii.ac.jp:00055763
2023-08-09T02:56:35Z
2778:332
2780:1275
3:62:5601:1884
Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation
山縣, 邦弘
ヤマガタ, クニヒロ
YAMAGATA, Kunihiro
前田, 清司
マエダ, セイジ
MAEDA, Seiji
Nakano, Toshihiro
Shiizaki, Kazuhiro
Miura, Yutaka
Matsui, Masahiro
Kosaki, Keisei
Mori, Shoya
Kishi, Takuya
Usui, Naoki
Yoshida, Masahide
Onaka, Tatsushi
Mizukami, Hiroaki
Kaneda, Ruri
Karasawa, Kazunori
Nitta, Kosaku
Kurosu, Hiroshi
Kuro-o, Makoto
open access
(c) The Author(s) 2019
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Nature
2019-12
eng
journal article
VoR
http://hdl.handle.net/2241/00161167
https://tsukuba.repo.nii.ac.jp/records/55763
31848393
https://doi.org/10.1038/s41598-019-55643-4
2045-2322
Scientific Reports
9
19247
https://tsukuba.repo.nii.ac.jp/record/55763/files/SR_9-19247.pdf
application/pdf
3.0 MB
2020-09-04